Thrombin functions during tissue factor-induced blood coagulation.

Tissue factor-induced blood coagulation was studied in 20 individuals, for varying periods of time during 54 months, in contact pathway-inhibited whole blood at 37 degrees C and evaluated in terms of the activation of various substrates. After quenching over time with inhibitors, the soluble phases were analyzed for thrombin-antithrombin III (TAT) complex formation, prothrombin fragments, platelet activation (osteonectin release), factor Va generation, fibrinopeptide (FP) A and FPB release, and factor XIII activation. TAT complex formation, for 35 experiments, showed an initiation phase (up to 4.6 +/- 0.6 minutes) in which thrombin was generated at an average rate of 0.93 +/- 0.3 nM/min catalyzed by about 1.3 pM prothrombinase yielding approximately 26 nM thrombin. During a subsequent propagation phase, thrombin was generated at a rate of 83.9 +/- 3.8 nM/min by about 120 pM prothrombinase, reaching ultimate levels of 851 +/- 53 nM. Clot time, determined subjectively, occurred at 4.7 +/- 0.2 minutes and correlated with the inception of the propagation phase. The thrombin concentrations associated with the transitions to rapid product formation are 510 +/- 180 pM for platelet activation (1.9 +/- 0.2 minutes), 840 +/- 280 pM for factor XIII activation and factor Va generation (2.2 +/- 0.6 minutes), 1.3 +/- 0.4 nM for FPA release (2.5 +/- 0.7 minutes), 1.7 +/- 0.5 nM for FPB release and prethrombin 2 (2.8 +/- 0.8 minutes), 7.0 +/- 2.2 nM for thrombin B chain (3.6 +/- 0.2 minutes), and 26 +/- 6.2 nM for the propagation phase of TAT formation (4.6 +/- 0.6 minutes). These results illustrate that the initial activation of thrombin substrates occurs during the initiation phase at less than 2 nM thrombin (0.2%). Most thrombin (96%) is formed well after clotting occurs.

[1]  A. Tulinsky,et al.  Molecular Interactions of Thrombin. , 1996, Seminars in thrombosis and hemostasis.

[2]  M. Nesheim,et al.  Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*) , 1995, The Journal of Biological Chemistry.

[3]  K. Mann,et al.  The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. , 1986, The Journal of biological chemistry.

[4]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[5]  K. Mann,et al.  Blood coagulation in hemophilia A and hemophilia C. , 1998, Blood.

[6]  P. Fay Subunit structure of thrombin-activated human factor VIIIa. , 1988, Biochimica et biophysica acta.

[7]  W. Kisiel,et al.  Anticoagulant properties of bovine plasma protein C following activation by thrombin. , 1977, Biochemistry.

[8]  K. Mann,et al.  Extrinsic pathway proteolytic activity. , 1993, Methods in enzymology.

[9]  R. D. Carlson,et al.  A simple method for the preparation of homogeneous phospholipid vesicles. , 1977, Biochemistry.

[10]  K. Mann,et al.  Blood clotting in minimally altered whole blood. , 1996, Blood.

[11]  K. Mann,et al.  Monoclonal antibodies to human coagulation factor V and factor Va , 1983 .

[12]  Mosesson Mw The roles of fibrinogen and fibrin in hemostasis and thrombosis. , 1992 .

[13]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[14]  K. Mann,et al.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.

[15]  Kenneth G. Mann,et al.  An Integrated Study of Fibrinogen during Blood Coagulation* , 1999, The Journal of Biological Chemistry.

[16]  W. N. Kelley,et al.  Textbook of Internal Medicine , 1989 .

[17]  K. Mann,et al.  Role of the membrane surface in the activation of human coagulation factor X. , 1992, The Journal of biological chemistry.

[18]  K. Mann,et al.  Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation. , 1979, Thrombosis research.

[19]  J. Shafer,et al.  Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. , 1983, The Journal of biological chemistry.

[20]  L. Lorand,et al.  ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN. , 1964, Archives of biochemistry and biophysics.

[21]  M. Mosesson The roles of fibrinogen and fibrin in hemostasis and thrombosis. , 1992, Seminars in hematology.

[22]  K. Mann,et al.  Multiple active forms of thrombin. IV. Relative activities of meizothrombins. , 1990, The Journal of biological chemistry.

[23]  K. Mann,et al.  Human platelets contain and secrete osteonectin, a major protein of mineralized bone. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Lüscher,et al.  Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets , 1967, Nature.